I agree with you on all points but the ASX market is the problem. As IMU's CF33 potential and results achieved so far have been ignored how in the world can get CHM any attention. The only way currently is an offer of any kind by big pharma. Look at IMU 10.5c sell line, if there was an accumulator it would have been swallowed, but there is Zero interest. Same here. IMO, if there is a turnaround, then probably first at IMU.
Market only understands $ and rock chip sample grades and may jump on the 2 letters AI and the element of H2, but nothing else.
GLTA
CHM Price at posting:
3.9¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)